Drug profile · INN
bleomycin sulfate
BLEOMYCIN SULFATE
bleomycin sulfate (BLEOMYCIN SULFATE) is a dna inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — bleomycin sulfate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
bleomycin sulfate (BLEOMYCIN SULFATE) is a dna inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is bleomycin sulfate?
bleomycin sulfate (BLEOMYCIN SULFATE) is a dna inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for bleomycin sulfate?
BLEOMYCIN SULFATE is a marketed brand name for bleomycin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bleomycin sulfate?
bleomycin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.